Molecular interaction of quercetin and its derivatives against nucleolin in breast cancer: in-silico and in-vitro study

References

• AlphaFold. (2022). AlphaFold protein structure database. https://www.alphafold.ebi.ac.uk/entry/A0A7I2V699
   Google Scholar
• Bellone, M. L., Fiengo, L., Cerchia, C., Cotugno, R., Bader, A., Lavecchia, A., De Tommasi, N., & Piaz, F. D. (2022). Impairment of nucleolin activity and phosphorylation by a trachylobane diterpene from Psiadia punctulata in cancer cells. International Journal of Molecular Sciences, 23(19), 11390. https://doi.org/10.3390/IJMS231911390/S1
   PubMed Web of Science ®Google Scholar
• Bose, S. K., Sengupta, T. K., Bandyopadhyay, S., & Spicer, E. K. (2006). Identification of Ebp1 as a component of cytoplasmic bcl-2 mRNP (messenger ribonucleoprotein particle) complexes. The Biochemical Journal, 396(1), 99–107. https://doi.org/10.1042/BJ20051548
   PubMedGoogle Scholar
• Bose, S., Tholanikunnel, T. E., Reuben, A., Tholanikunnel, B. G., & Spicer, E. K. (2016). Regulation of nucleolin expression by miR-194, miR-206, and HuR. Molecular and Cellular Biochemistry, 417(1-2), 141–153. https://doi.org/10.1007/S11010-016-2721-2/METRICS
   PubMed Web of Science ®Google Scholar
• Carvalho, L. S., Gonçalves, N., Fonseca, N. A., & Moreira, J. N. (2021). Cancer stem cells and nucleolin as drivers of carcinogenesis. Pharmaceuticals (Basel, Switzerland), 14(1), 60. https://doi.org/10.3390/ph14010060
   PubMedGoogle Scholar
• Cho, K., Choi, E. S., Kim, J. H., Son, J. W., & Kim, E. (2022). Numerical learning of deep features from drug-exposed cell images to calculate IC50 without staining. Scientific Reports, 12(1), 6610. https://doi.org/10.1038/s41598-022-10643-9
   PubMed Web of Science ®Google Scholar
• Colovos, C., & Yeates, T. O. (1993). Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Science: A Publication of the Protein Society, 2(9), 1511–1519. https://doi.org/10.1002/PRO.5560020916
   PubMed Web of Science ®Google Scholar
• DESMOND (2021). Desmond molecular dynamics system. In Maestro-Desmond Interoperability Tools. D. E. Shaw Research.
   Google Scholar
• Duo, J., Ying, G. G., Wang, G. W., & Zhang, L. (2012). Quercetin inhibits human breast cancer cell proliferation and induces apoptosis via Bcl-2 and Bax regulation. Molecular Medicine Reports, 5(6), 1453–1456. https://doi.org/10.3892/MMR.2012.845/HTML
   PubMed Web of Science ®Google Scholar
• Essler, M., Gärtner, F. C., Neff, F., Blechert, B., Senekowitsch-Schmidtke, R., Bruchertseifer, F., Morgenstern, A., & Seidl, C. (2012). Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis. European Journal of Nuclear Medicine and Molecular Imaging, 39(4), 602–612. https://doi.org/10.1007/S00259-011-2023-6
   PubMed Web of Science ®Google Scholar
• Glide (2021). Glide. Schrödinger, LLC.
   Google Scholar
• Ham, S. H., Min, K. A., & Shin, M. C. (2017). Molecular tumor targeting of gelonin by fusion with F3 peptide. Acta Pharmacologica Sinica, 38(6), 897–906. https://doi.org/10.1038/aps.2017.20
   PubMed Web of Science ®Google Scholar
• Jaguar  . (2021). Jaguar. Schrödinger, LLC.
   Google Scholar
• Jia, W., Yao, Z., Zhao, J., Guan, Q., & Gao, L. (2017). New perspectives of physiological and pathological functions of nucleolin (NCL). Life Sciences, 186, 1–10. https://doi.org/10.1016/J.LFS.2017.07.025
   PubMed Web of Science ®Google Scholar
• Kabirian-Dehkordi, S., Chalabi-Dchar, M., Mertani, H. C., Le Guellec, D., Verrier, B., Diaz, J. J., Mehrgardi, M. A., & Bouvet, P. (2019). AS1411-conjugated gold nanoparticles affect cell proliferation through a mechanism that seems independent of nucleolin. Nanomedicine: Nanotechnology, Biology, and Medicine, 21, 102060. https://doi.org/10.1016/J.NANO.2019.102060
   PubMed Web of Science ®Google Scholar
• Khaghani, S., Yajloo, M. M., Paknejad, M., Shariftabrizi, A., Pasalar, P., & Razi, F. (2011). Selective cytotoxicity and apoptogenic activity of hibiscus sabdariffa aqueous extract against MCF-7 human breast cancer cell line. Journal of Cancer Therapy, 02(03), 394–400. https://doi.org/10.4236/jct.2011.23054
   Google Scholar
• Kifayat Ullah, M. (2017). Anti-diabetic activity of compound “2-[(trimethylsilyl) oxy]-methyl ester (CAS) methyl-o-trim-ethyl-silylsalicylate” isolated from Pericampylus glaucus (Lam) Merr in STZ-induced diabetic rats.
   Google Scholar
• Krust, B., El Khoury, D., Soundaramourty, C., Nondier, I., & Hovanessian, A. G. (2011). Suppression of tumorigenicity of rhabdoid tumor derived G401 cells by the multivalent HB-19 pseudopeptide that targets surface nucleolin. Biochimie, 93(3), 426–433. https://doi.org/10.1016/J.BIOCHI.2010.10.015
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., MacArthur, M. W., & Thornton, J. M. (2012). PROCHECK: Validation of protein-structure coordinates, International Tables for Crystallography, F(21.4), 684–687. https://doi.org/10.1107/97809553602060000882
   Google Scholar
• Laskowski, R. A., Rullmann, J. A. C., MacArthur, M. W., Kaptein, R., & Thornton, J. M. (1996). AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. Journal of Biomolecular NMR, 8(4), 477–486. https://doi.org/10.1007/BF00228148
   PubMed Web of Science ®Google Scholar
• Lüthy, R., Bowie, J. U., & Eisenberg, D. (1992). Assessment of protein models with three-dimensional profiles. Nature, 356(6364), 83–85. https://doi.org/10.1038/356083A0
   PubMed Web of Science ®Google Scholar
• MacroModel (2021). Schrödinger Release 2023-1. Schrödinger, LLC.
   Google Scholar
• Maestro (2021). Maestro. Schrödinger, LLC.
   Google Scholar
• Mukherjee, A., Mishra, S., Kotla, N. K., Manna, K., Roy, S., Kundu, B., Bhattacharya, D., Das Saha, K., & Talukdar, A. (2019). Semisynthetic quercetin derivatives with potent antitumor activity in colon carcinoma. ACS Omega. 4(4), 7285–7298. https://doi.org/10.1021/ACSOMEGA.9B00143/ASSET/IMAGES/LARGE/AO-2019-00143B_0002.JPEG
   Web of Science ®Google Scholar
• NCBI (2022). Nucleolin [Homo sapiens]-Protein-NCBI. https://www.ncbi.nlm.nih.gov/protein/NP_005372.2
   Google Scholar
• Prime (2021). Prime. Schrödinger, LLC.
   Google Scholar
• Ranganathan, S., Halagowder, D., & Sivasithambaram, N. D. (2015). Quercetin suppresses twist to induce apoptosis in MCF-7 breast cancer cells. PLoS One, 10(10), e0141370. https://doi.org/10.1371/JOURNAL.PONE.0141370
   PubMed Web of Science ®Google Scholar
• Rayamajhi, N., Kim, S. K., Go, H., Joe, Y., Callaway, Z., Kang, J. G., Ryter, S. W., & Chung, H. T. (2013). Quercetin induces mitochondrial biogenesis through activation of HO-1 in HEPG2 cells. Oxidative Medicine and Cellular Longevity, 2013, 154279–154210. https://doi.org/10.1155/2013/154279
   PubMed Web of Science ®Google Scholar
• Reyes-Farias, M., & Carrasco-Pozo, C. (2019). The anti-cancer effect of quercetin: Molecular implications in cancer metabolism. International Journal of Molecular Sciences, 20(13), 3177. https://doi.org/10.3390/IJMS20133177
   PubMed Web of Science ®Google Scholar
• Saha, A., Duchambon, P., Masson, V., Loew, D., Bombard, S., & Teulade-Fichou, M.-P. (2020). Nucleolin discriminates drastically between long-loop and short loop quadruplexes. Biochemistry, 59(12), 1261–1272. https://doi.org/10.1021/acs.biochem.9b01094
   PubMed Web of Science ®Google Scholar
• Santoshi, S., & Naik, P. K. (2014). Molecular insight of isotypes specific β-tubulin interaction of tubulin heterodimer with noscapinoids. Journal of Computer-Aided Molecular Design, 28(7), 751–763. https://doi.org/10.1007/S10822-014-9756-9/METRICS
   PubMed Web of Science ®Google Scholar
• Shaw, S., Singh, P., Mishra, R., Singh, R., Nayak, R., & Bose, S. (2022). Cancer therapeutics strategy using nano-carrier mediated natural drugs. Journal of Achievements in Materials and Manufacturing Engineering, 114(1), 32–41. https://doi.org/10.5604/01.3001.0016.1481
   Google Scholar
• SiteMap (2021). SiteMap. Schrödinger, LLC.
   Google Scholar
• Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/CAAC.21660
   PubMed Web of Science ®Google Scholar
• Tang, S. M., Deng, X. T., Zhou, J., Li, Q. P., Ge, X. X., & Miao, L. (2020). Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 121, 109604. https://doi.org/10.1016/J.BIOPHA.2019.109604
   PubMed Web of Science ®Google Scholar
• Vasaturo, M., Cotugno, R., Fiengo, L., Vinegoni, C., Dal Piaz, F., & De Tommasi, N. (2018). The anti-tumor diterpene oridonin is a direct inhibitor of Nucleolin in cancer cells. Scientific Reports, 8(1), 16735. https://doi.org/10.1038/s41598-018-35088-x
   PubMedGoogle Scholar
• Vestergaard, A. L., Knudsen, U. B., Munk, T., Rosbach, H., & Martensen, P. M. (2011). Transcriptional expression of type-I interferon response genes and stability of housekeeping genes in the human endometrium and endometriosis. Molecular Human Reproduction, 17(4), 243–254. https://doi.org/10.1093/MOLEHR/GAQ100
   PubMed Web of Science ®Google Scholar
• Vindigni, G., Raniolo, S., Iacovelli, F., Unida, V., Stolfi, C., Desideri, A., & Biocca, S. (2021). AS1411 aptamer linked to DNA nanostructures diverts its traffic inside cancer cells and improves its therapeutic efficacy. Pharmaceutics, 13(10), 1671. https://doi.org/10.3390/PHARMACEUTICS13101671/S1
   PubMed Web of Science ®Google Scholar
• Wang, J., Wu, J., Li, X., Liu, H., Qin, J., Bai, Z., Chi, B., & Chen, X. (2018). Identification and validation nucleolin as a target of curcumol in nasopharyngeal carcinoma cells. Journal of Proteomics, 182, 1–11. https://doi.org/10.1016/J.JPROT.2018.04.025
   PubMed Web of Science ®Google Scholar
• Wizard, P. P. (2021). Protein preparation wizard: Epik. Schrödinger, LLC.
   Google Scholar
• Yamada, T., Park, C. S., Shen, Y., Rabin, K. R., & Lacorazza, H. D. (2014). G0S2 inhibits the proliferation of K562 cells by interacting with nucleolin in the cytosol. Leukemia Research, 38(2), 210–217. https://doi.org/10.1016/J.LEUKRES.2013.10.006
   PubMed Web of Science ®Google Scholar